share_log

Medical Properties Trust Inc | 8-K: Current report

Medical Properties Trust Inc | 8-K: Current report

Medical Properties Trust | 8-K:重大事件
SEC announcement ·  03/15 05:11
牛牛AI助理已提取核心訊息
Medical Properties Trust Inc. reported on March 8, 2024, that its Compensation Committee has granted performance-based restricted stock unit awards to key executives, CEO Edward K. Aldag, Jr. and CFO R. Steven Hamner. The awards consist of 2,700,000 restricted stock units, which will vest based on the achievement of specific stock price appreciation hurdles. These hurdles are set at $7.00, $8.50, and $10.00, representing increases of 67%, 103%, and 139% above the grant date stock price, respectively. The RSUs are cash-settled, with the payment amount determined by the average closing price of the company's common stock over the five trading days ending on the vesting date. The grants are part of the Amended and Restated 2019 Equity Incentive Plan and aim to motivate and retain the executives to execute the company's strategic business plan and enhance shareholder value. The performance period for the RSUs extends to December 31, 2027, with vesting contingent on continued employment and the achievement of performance metrics.
Medical Properties Trust Inc. reported on March 8, 2024, that its Compensation Committee has granted performance-based restricted stock unit awards to key executives, CEO Edward K. Aldag, Jr. and CFO R. Steven Hamner. The awards consist of 2,700,000 restricted stock units, which will vest based on the achievement of specific stock price appreciation hurdles. These hurdles are set at $7.00, $8.50, and $10.00, representing increases of 67%, 103%, and 139% above the grant date stock price, respectively. The RSUs are cash-settled, with the payment amount determined by the average closing price of the company's common stock over the five trading days ending on the vesting date. The grants are part of the Amended and Restated 2019 Equity Incentive Plan and aim to motivate and retain the executives to execute the company's strategic business plan and enhance shareholder value. The performance period for the RSUs extends to December 31, 2027, with vesting contingent on continued employment and the achievement of performance metrics.
醫療地產信託公司於2024年3月8日報告稱,其薪酬委員會已向主要高管、首席執行官小愛德華·阿爾達格和首席財務官史蒂芬·哈姆納發放了基於績效的限制性股票單位獎勵。獎勵包括2,700,000個限制性股票單位,這些單位將根據特定股價升值障礙的實現情況進行歸屬。這些障礙設定爲7.00美元、8.50美元和10.00美元,分別比授予日股價上漲67%、103%和139%。限制性股票單位以現金結算,付款金額由截至歸屬日的五個交易日公司普通股的平均收盤價確定。這些補助金是經修訂和重述的2019年股權激勵計劃的一部分,旨在激勵和留住高管執行公司的戰略業務計劃並提高股東價值。限制性股票單位的績效期延長至2027年12月31日,歸屬取決於持續就業和績效指標的實現。
醫療地產信託公司於2024年3月8日報告稱,其薪酬委員會已向主要高管、首席執行官小愛德華·阿爾達格和首席財務官史蒂芬·哈姆納發放了基於績效的限制性股票單位獎勵。獎勵包括2,700,000個限制性股票單位,這些單位將根據特定股價升值障礙的實現情況進行歸屬。這些障礙設定爲7.00美元、8.50美元和10.00美元,分別比授予日股價上漲67%、103%和139%。限制性股票單位以現金結算,付款金額由截至歸屬日的五個交易日公司普通股的平均收盤價確定。這些補助金是經修訂和重述的2019年股權激勵計劃的一部分,旨在激勵和留住高管執行公司的戰略業務計劃並提高股東價值。限制性股票單位的績效期延長至2027年12月31日,歸屬取決於持續就業和績效指標的實現。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。